Granules India gets marketing approval for Acetaminophen Extended-Release Tablets
30th Aug 2021

Granules India has received marketing approval from Health Canada for Acetaminophen Extended-Release Tablets OTC, 650mg for the treatment of Arthritis Pain. The product manufactured by Granules is a bioequivalent to the reference listed drug, Tylenol Extended Release 650 Tablets. The drug will be manufactured at the Granules manufacturing facility located in Gagillapur, Hyderabad. Granules now have a total of 2 ANDS approvals from Health Canada.

Granules India is manufacturer and supplier of pharmaceutical products. Its products include active pharmaceutical ingredients (API) like tablets, caplets, rapid release, pharmaceutical, formulation intermediates (PFI) and Finished Dosages (FDs).